484 related articles for article (PubMed ID: 27430290)
1. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
2. Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
Toriola AT; Luo S; Thomas TS; Drake BF; Chang SH; Sanfilippo KM; Carson KR
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):169-175. PubMed ID: 31685560
[TBL] [Abstract][Full Text] [Related]
3. Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus.
Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Langenbecks Arch Surg; 2020 May; 405(3):313-324. PubMed ID: 32367394
[TBL] [Abstract][Full Text] [Related]
4. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
[TBL] [Abstract][Full Text] [Related]
6. Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.
Chaiteerakij R; Petersen GM; Bamlet WR; Chaffee KG; Zhen DB; Burch PA; Leof ER; Roberts LR; Oberg AL
J Clin Oncol; 2016 Jun; 34(16):1898-904. PubMed ID: 27069086
[TBL] [Abstract][Full Text] [Related]
7. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
Pretta A; Ziranu P; Puzzoni M; Lai E; Orsi G; Liscia N; Molinaro E; Mariani S; Riggi L; Rovesti G; Dubois M; Migliari M; Persano M; Saba G; Impera V; Musio F; Batzella E; Demurtas L; Pusceddu V; Astara G; Faloppi L; Casadei Gardini A; Andrikou K; Cascinu S; Scartozzi M
Tumori; 2021 Dec; 107(6):550-555. PubMed ID: 33243068
[TBL] [Abstract][Full Text] [Related]
8. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis.
Yang A; Zylberberg HM; Rustgi SD; Amin SP; Bar-Mashiah A; Boffetta P; Lucas AL
Sci Rep; 2021 Jan; 11(1):1038. PubMed ID: 33441781
[TBL] [Abstract][Full Text] [Related]
10. Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.
Lee KT; Yeh YH; Chang SH; See LC; Lee CH; Wu LS; Liu JR; Kuo CT; Wen MS
Medicine (Baltimore); 2017 Jul; 96(28):e7507. PubMed ID: 28700501
[TBL] [Abstract][Full Text] [Related]
11. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
[TBL] [Abstract][Full Text] [Related]
12. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
13. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
Kozak MM; Anderson EM; von Eyben R; Pai JS; Poultsides GA; Visser BC; Norton JA; Koong AC; Chang DT
Pancreas; 2016 Jan; 45(1):64-70. PubMed ID: 26474429
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis.
Zylberberg HM; Rustgi SD; Yang A; Aronson A; Kessel E; Amin S; Lucas AL
Gut Liver; 2021 Sep; 15(5):782-790. PubMed ID: 34158422
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
16. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
[TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
18. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
[TBL] [Abstract][Full Text] [Related]
19. The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis.
Li Y; Liu W; Zhao L; Xu Y; Yan T; Yang Q; Pei Q; Güngör C
Med Sci Monit; 2020 May; 26():e921515. PubMed ID: 32358953
[TBL] [Abstract][Full Text] [Related]
20. Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer.
Cerullo M; Gani F; Chen SY; Canner J; Pawlik TM
J Gastrointest Surg; 2016 Sep; 20(9):1572-80. PubMed ID: 27255657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
